Bluejay Diagnostics, Inc. Financing Cash Flow
Bluejay Diagnostics, Inc. (BJDX) reported Financing Cash Flow of $7.68 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-12
- Bluejay Diagnostics, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $7.56M, a 123.50% increase year-over-year.
- Bluejay Diagnostics, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $124.10K.
- Bluejay Diagnostics, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $3.71M.
- Bluejay Diagnostics, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was -$1.01K.
- Bluejay Diagnostics, Inc. net cash provided by (used in) financing activities for fiscal 2025 was $7.09M, a 30.63% decline from fiscal 2024.
- Bluejay Diagnostics, Inc. net cash provided by (used in) financing activities for fiscal 2024 was $10.22M, a 819.52% increase from fiscal 2023.
- Bluejay Diagnostics, Inc. net cash provided by (used in) financing activities for fiscal 2023 was $1.11M, a 13665.47% increase from fiscal 2022.
- Bluejay Diagnostics, Inc. net cash provided by (used in) financing activities for fiscal 2022 was $8.07K, a 99.96% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 3 month as first filed | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 6 month as first filed | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 9 month as first filed | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $7.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $7.68M 10-Q · filed 2026-08-12 | $11.39M derived: sum of 3 quarters · filed 2026-08-12 | $11.39M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2026-03-31 | $124.10K 10-Q · filed 2026-05-07 | $3.84M derived: sum of 2 quarters · filed 2026-05-07 | $3.83M derived: sum of 3 quarters · filed 2026-05-07 | $7.22M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-12-31 | $3.71M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | $3.71M derived: sum of 2 quarters · filed 2026-03-06 | $7.09M derived: sum of 3 quarters · filed 2026-08-12 | $7.09M 10-K · filed 2026-03-06 | ||||
| 2025-09-30 | -$1.01K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $3.38M derived: sum of 2 quarters · filed 2026-08-12 | $3.38M 10-Q · filed 2025-11-07 | $3.38M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-06-30 | $3.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $3.38M 10-Q · filed 2026-08-12 | $3.38M derived: sum of 3 quarters · filed 2026-08-12 | $3.23M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-03-31 | -$985.00 10-Q · filed 2026-05-07 | -$2.31K derived: sum of 2 quarters · filed 2026-05-07 | -$150.17K derived: sum of 3 quarters · filed 2026-05-07 | $7.43M derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | -$1.33K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | -$149.19K derived: sum of 2 quarters · filed 2026-03-06 | $7.43M derived: sum of 3 quarters · filed 2026-03-06 | $10.22M 10-K · filed 2026-03-06 | $10.22M 10-K · filed 2025-03-31 | |||
| 2024-09-30 | -$147.86K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $7.43M derived: sum of 2 quarters · filed 2025-11-07 | $10.22M 10-Q · filed 2025-11-07 | $9.93M 10-Q · filed 2024-11-07 | $10.22M derived: sum of 4 quarters · filed 2025-11-07 | |||
| 2024-06-30 | $7.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $10.37M 10-Q · filed 2025-08-07 | $10.31M 10-Q · filed 2024-08-14 | $10.37M derived: sum of 3 quarters · filed 2025-08-07 | $11.54M derived: sum of 4 quarters · filed 2025-08-07 | |||
| 2024-03-31 | $2.79M 10-Q · filed 2025-05-13 | $2.78M 10-Q · filed 2024-05-15 | $2.79M derived: sum of 2 quarters · filed 2025-05-13 | $3.96M derived: sum of 3 quarters · filed 2025-05-13 | $3.96M derived: sum of 4 quarters · filed 2025-05-13 | |||
| 2023-12-31 | -$3.05K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $1.17M derived: sum of 2 quarters · filed 2025-03-31 | $1.17M derived: sum of 3 quarters · filed 2025-03-31 | $1.11M 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | $1.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $1.17M derived: sum of 2 quarters · filed 2024-11-07 | $1.11M 10-Q · filed 2024-11-07 | |||||
| 2023-06-30 | -$2.68K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$61.48K 10-Q · filed 2024-08-14 | ||||||
| 2023-03-31 | -$58.80K 10-Q · filed 2024-05-15 | |||||||
| 2022-12-31 | $8.07K 10-K · filed 2024-03-28 | |||||||
| 2021-12-31 | $19.26M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | $20.31M derived: sum of 2 quarters · filed 2023-03-20 | $22.82M derived: sum of 3 quarters · filed 2023-03-20 | $22.53M 10-K · filed 2023-03-20 | ||||
| 2021-09-30 | $1.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $3.56M derived: sum of 2 quarters · filed 2022-11-09 | $3.27M 10-Q · filed 2022-11-09 | $4.26M derived: sum of 4 quarters · filed 2022-11-09 | ||||
| 2021-06-30 | $2.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $2.22M 10-Q · filed 2022-08-10 | $3.21M derived: sum of 3 quarters · filed 2022-08-10 | |||||
| 2021-03-31 | -$290.75K 10-Q · filed 2022-05-09 | $703.70K derived: sum of 2 quarters · filed 2022-05-09 | ||||||
| 2020-12-31 | $994.45K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $1.33M 10-K · filed 2022-03-10 | ||||||
| 2020-09-30 | $330.61K 10-Q · filed 2021-12-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |